Search Within

Advanced Practice Providers

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (89)
  2. Journal Article (68)
  3. Review (2)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (161)
  2. Department of Medicine (124)
  3. Nursing (114)
  4. Survivorship Research (89)
  5. Epidemiology and Biostatistics (81)
  6. GSK Faculty (76)

More Groups

People
  1. Ahmet Dogan (40)
  2. Maria Arcila (29)
  3. Sergio Giralt (20)
  4. Alison Moskowitz (19)
  5. Gunjan Shah (18)
  6. Kimberly Van Zee (17)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (22)
  6. 2020 (12)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (29)
  3. Neuro-Oncology (8)
  4. Annals of Surgical Oncology (6)
  5. Cancer Research (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. American Society of Hematology (30)
  3. American Association for Cancer Research (17)
  4. Oxford University Press (10)
  5. Elsevier Inc. (9)
  6. Wiley Blackwell (8)

More Publishers

Results (161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of BRCA-altered uterine sarcoma treated with poly(ADP-ribose) polymerase inhibitors
    Journal Article

    Rao, M.; Merrill, M.; Troxel, M.; Chiang, S.; Momeni-Boroujeni, A.; Hensley, M. L.; Schram, A. M.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical and pathologic characteristics of cytologically indeterminate thyroid nodules with non-V600E BRAF alterations
    Journal Article

    Instrum, R.; Swartzwelder, C. E.; Ghossein, R. A.; Xu, B.; Givi, B.; Wong, R. J.; Untch, B. R.; Morris, L. G. T.
    Cancers (2025)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Precision oncology: 2024 in review
    Review

    Repetto, M.; Fernandez, N.; Drilon, A.; Chakravarty, D.
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Interception treatment strategy for incidental lesions in children, adolescents and young adults (AYA) using laser interstitial thermal therapy (LITT)
    Meeting Abstract

    Nguyen, R. H.; Guadix, S.; Donzelli, M.; Sanders, C.; Rosenblum, M. K.; Bale, T. A.; Greenfield, J. P.; Souweidane, M. M.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Isatuximab for delayed red cell engraftment after allogeneic hematopoietic cell transplantation
    Journal Article

    Nauffal, M.; Eng, S.; Lin, A.; Chan, A.; Mazzerella, K.; Giralt, S.; Perales, M. A.; Gyurkocza, B.
    Case Reports in Hematology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save